open access to scientific and medical research

A part of Taylor & Francis Group

Back to Journals » Drug Design, Development and Therapy » Volume 12

Review

Noteworthy comment: Diabetic retinopathy remains a challenging condition to manage. The traditional laser treatment for diabetic macular oedema is being replaced by the anti-VEGF agents and steroid implants; however, retinal laser photocoagulation remains the gold standard for proliferative diabetic retinopathy. The present review presents the current knowledge regarding the potential therapeutic effect of anti-angiogenic cytokines on diabetic retinopathy.

Highly-accessed

Antiangiogenic cytokines as potential new therapeutic targets for resveratrol in diabetic retinopathy

Total article views		HTML views	PDF downloads	Totals
19,498	Dovepress*	17,950+	1,593	19,543
	PubMed Central*	1,548	503	2,051
	Totals	19,498	2,096	21,594
*Since 3 July 2018

Total mentioned	Facebook	Delicious	Reddit	Twitter	Others
6	1	0	0	2	3

View citations on PubMed and Google Scholar